scispace - formally typeset
A

Anne-Marie Lossi

Researcher at French Institute of Health and Medical Research

Publications -  15
Citations -  479

Anne-Marie Lossi is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: X chromosome & Gene. The author has an hindex of 10, co-authored 15 publications receiving 456 citations. Previous affiliations of Anne-Marie Lossi include Aix-Marseille University & Necker-Enfants Malades Hospital.

Papers
More filters
Journal ArticleDOI

Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia

TL;DR: Progress in neuroimaging has aided the approach to brain malformations associated with mental retardation hence allowing a new classification of conditions previously described as non-syndromic, based on very similar brain mal Formations in affected subjects.
Journal ArticleDOI

Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males.

TL;DR: It is proposed that the severe MR of the affected males in this family is due to the absence of the KIAA2022 gene product, and the high expression of this gene in fetal brain and in the adult cerebral cortex could be consistent with a role in brain development and/or cognitive function.
Journal ArticleDOI

Determination of the Genomic Structure of the XNP/ATRX Gene Encoding a Potential Zinc Finger Helicase

TL;DR: Using a vectorette strategy, the intron/exon boundaries of the XNP/ATR-X gene are identified and sequenced, suggesting that mutations will be predominantly found in the helicase region as well as in the zinc finger regions and leading to a large screening of additional patients.
Journal ArticleDOI

Mutation of the XNP/ATR-X gene in a family with severe mental retardation, spastic paraplegia and skewed pattern of X inactivation: demonstration that the mutation is involved in the inactivation bias.

TL;DR: This work has shown clear improvements in the quality of life of patients diagnosed with central giant cell granuloma, and these improvements have been confirmed by a follow-up study at the National Institutes of Health in Washington DC.